SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " oncology " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Filippo Alongi: Science, Collaboration, and Friendship Beyond Borders at KOSRO 2026
Filippo Alongi: Science, Collaboration, and Friendship Beyond Borders at KOSRO 2026 / cancer, Filippo Alongi, KOSRO 2026, OncoDaily, Oncology, radiation
Nabil Chehab: “What Science Can Do” - Advancing Next-Generation Cell Therapies
Nabil Chehab: “What Science Can Do” - Advancing Next-Generation Cell Therapies / AstraZeneca, cancer, Cell Therapy, Nabil Chehab, OncoDaily, Oncology
Million dollar shot gala to benefit cancer care services
Naples Cancer Advisors, a community-based, non-profit organization that provides free consultative oncology services to cancer patients and their families, announced it will host the inaugural Million Dollar Shot fundraising gala
The future of oncology: Early-career scientists need mentorship and a new academic model
The early years of a scientific career can be unforgiving. For junior investigators, starting a lab is a high-pressure moment: Securing that first National Institutes of Health grant, publishing meaningful work, and proving they belong. It’s a period marked by uncertainty and, often, anxiety about whether it will all come together. I’ve seen that play […]
PureTech Health H1 Earnings Call Highlights
PureTech Health (NASDAQ:PRTC) outlined progress across its portfolio in its 2026 half-year results call, highlighting external financings for Celea Therapeutics and Seaport Therapeutics, regulatory progress at Gallop Oncology, and a strategy centered on earlier external funding for its founded entit
Vanderbilt Health and Siemens Healthineers launch $87M Value Partnership to deliver advanced technology, elevate patient care
Value Partnership will drive technology upgrades and standardization across diagnostic imaging and radiation oncology, promote workforce development Collaboration will empower health care innovation through scalable artificial intelligence uses in radiology, personalized medicine and workflow automation
COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings
Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...
Lunit and Discovery Life Sciences Collaborate to Expand AI-Powered Tissue Analysis for Biopharma Research
/PRNewswire/ -- Lunit (KRX: 328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced a strategic collaboration with...
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are currently under review by the FDA for approval this year.
Members of Congress seek to stabilize radiologist pay in Medicare program
A broad coalition of doc groups has endorsed the measure, including the AMA, American College of Radiology and the American Society for Radiation Oncology.
Yale doctor on caring for mental health in cancer patients
NEW HAVEN, Conn. (WTNH) — The mental state of cancer patients is a part of care that many people may not think about. Gabe Cartagena, Ph.D., the clinical director of the Yale Psycho-Oncology Progra…
American College of Radiology outlines 2027 Medicare fee schedule’s impact on imaging pay
ACR said the document compares newly proposed payment amounts against 2026 ones across all individual, radiology- and radiation oncology-related codes.
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos
In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads. The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care.
Health Sense by Cigna Healthcare: How it works, AI, clinical support, and availability
Health Sense connects relevant data, context and clinical expertise to help Cigna Healthcare teams deliver more personalized, continuous support – so people can make informed decisions and act sooner. A phased rollout for eligible customers with oncology and cardiometabolic health needs will begin in early 2027.
Michigan Medicine, UM Health-Sparrow expand precision oncology program in Lansing
University of Michigan Health-Sparrow and Michigan Medicine are expanding the use of precision oncology in Lansing.
Cigna Group (CI) Could Be 56% Undervalued Following Its Health Sense Rollout
Health Sense rollout and what it could mean for Cigna Group stock Cigna Group (CI) has put its Health Sense platform at the center of a push to link health data, benefits and clinical support into a single experience for oncology and cardiometabolic patients. The model ties together information on medical history, behavioral health, pharmacy coverage, prior interactions and expected costs, then uses that context to tailor outreach and care coordination through existing Cigna Healthcare...
The Future of Lymphoma Care Is Moving Forward With Science | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the appointment of Nelson Azoulay as Chief Business Officer. Mr. Azoulay joins Pyxis Oncology with more than 15 years of experience in corporate strategy, business development, and value-creating transactions across the biopharma industry, including deep antibody-drug conjugate (ADC) experience. In his role,
Hayes receives 2026 ESMO Breast Cancer Award
Daniel F. Hayes, M.D., was selected by the European Society for Medical Oncology, ESMO, for the 2026 ESMO Breast Cancer Award.
Kettering Health Pharmacist Receives Ohio Resident of the Year Honor
Just months after returning to Kettering Health as a clinical oncology pharmacist, Annie Weckesser has received one of Ohio's top honors for pharmacy residents.
UNC Health plans Wilmington hospital
UNC Health plans to create a community hospital on a 62-acre proposed site in New Hanover County, pending regulatory approvals, according to an announcement Monday morning. “Planned for the southeast corner of South 17th Street and Shipyard Boulevard, the site was selected for its accessibility and its geographic infill capacity in serving a rapidly growing region,” according to the release. “This project marks a significant step forward in UNC Health’s commitment to improving access to primary care and specialty care closer to home.” Officials said the proposed hospital would offer a range of specialties, including emergency care, cardiology, oncology, OBGYN and more. While the not-for-profit, state-owned health system’s officials are planning the hospital, the proposal still requires state approval through North Carolina’s certificate of need (CON) process before it can become a reality. UNC Health is targeting an opening date of 2030, the release stated, and “will continue to engage openly with local community leaders and residents and share updates as plans evolve and progress is made towards achieving CON approval.” The state’s CON law requires healthcare providers to obtain a CON from the N.C. Department of Health and Human Services before developing or offering what the department’s website dubs “a new institutional health service.” The term encompasses a wide range of facilities, including hospitals. The news of UNC Health’s Wilmington plans follows the recent addition of Ernie Bovio to UNC Health. Bovio, who had served as president of the Novant Health Coastal Region since 2024, became regional president of UNC Health’s Southeast Coastal Region in April. “This is an important first step in our commitment to ensuring that families in Wilmington and the surrounding areas have access to the high-quality, compassionate care they deserve – right here at home,” Bovio stated in the release. “As I’ve listened to my own neighbors and community members across the region, I’ve heard a clear message: Wilmington is ready for more choice in healthcare – and UNC Health is ready to deliver it.” According to the release, Wilmington Health – one of the largest independent, physician-owned practices in Southeastern North Carolina – also supports the project, and its providers are expected to participate on the medical staff of the new facility. “Wilmington Health has served this community for more than 50 years, and we know firsthand that our patients are interested in choice,” stated Jeff James, CEO of Wilmington Health, in the release. “We strongly support UNC Health’s plan to bring a new community hospital to our region – closing critical gaps in specialty care and ensuring families across our region have options to access the services they need, right here at home.”
The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long”
The United States has a translation problem. Scientific breakthroughs in oncology are accelerating, but clinical trial infrastructure hasn’t kept pace. The solution: Speed up clinical trial enrollment by using AI to reduce costs and eliminate bureaucratic red tape. Tasks that ordinarily require hours of manual work for each patient in a single study can now […]
Nathan J. Nordmann, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spinal Oncology and Co-Director of Spinal Radiosurgery
August 27, 2026 – Fellowship-trained neurosurgeon Nathan J. Nordmann, M.D., has joined Baptist Health Miami Neuroscience as director of spinal oncology and co-director of spinal radiosurgery. He specializes in the surgical treatment of conditions affecting the brain and spine, with advanced expertise in primary and metastatic spinal tumors, complex spinal pathology and minimally invasive surgical techniques. […]
Radiation oncology providers form nonprofit network in bid to preserve independence
"Physicians should not have to surrender their independence to survive, and families deserve care close to home," those involved with the new Anoma Cancer Collective say.
RWJBarnabas Health and Rutgers Cancer Institute Among Only Six Health Systems Nationwide
RWJBarnabas Health and Rutgers Cancer Institute have earned a systemwide accreditation from the American Society for Radiation Oncology’s (ASTRO) APEx – Accreditation Program for Excellence®, a national program recognizing radiation oncology across the entire health system for meeting rigorous national standards for safety, quality and patient-centered care.
Julien Boone Heads to ESMO 2026 to Explore Emerging Science in Oncology
Julien Boone Heads to ESMO 2026 to Explore Emerging Science in Oncology / cancer, cancer medicines, esmo 2026, European Society for Medical Oncology, Fanny
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc....
2026 CGT Report: From Science to Patient Access
Explore findings from the 2026 Cell and Gene Therapy Report on oncology adoption, emerging specialties, reimbursement and AI-enabled patient access.
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y., May 07, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the first quarter ended March 31, 2026.
New UI clinic pilots exercise treatments to improve health of cancer patients, survivors
Cancer patients and survivors are working with a new UI exercise oncology clinic to help with symptoms and health.
How Will Patient Voices Influence Digestive Health Policy and Research? - Digestive Cancers Europe
How Will Patient Voices Influence Digestive Health Policy and Research? - Digestive Cancers Europe / cancer, Digestive Cancers Europe, OncoDaily, Oncology,
Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
Shield Across America mobile screening tour launches during Colorectal Cancer Awareness Month to address nation’s dangerously low screening rates by bringing Shield blood test directly to Americans Route will focus on rural communities across the country with the lowest screening rates and highest CRC incidence and mortality Shield is proven to increase screening rates with a 93% adherence Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile screening tour bringing Shield, the first and only FDA-approved blood test as a primary colorectal cancer (CRC) screening option and recommended in national guidelines , directly to over 100 communities across the country from Las Vegas to Hartford, Atlanta and more. Mobile screening bus providing Shield by Guardant Health, the first and only FDA-approved blood test for primary colorectal cancer screening From national sporting events to
FDA authorizes early access for experimental pancreatic cancer pill
The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the worst survival odds in oncology.
Aaron Goodman: Simplified CD Marker Profiles for Leukemia Classification
Aaron Goodman: Simplified CD Marker Profiles for Leukemia Classification / Aaron Goodman, cancer, Leukemia, OncoDaily, Oncology
Young Investigators Can Receive Free Registration and Travel Support - MASCC
Young Investigators Can Receive Free Registration and Travel Support - MASCC / cancer, MASCC, MASCC27, OncoDaily, Oncology, Young Investigator Award
Life Sciences Companies Present Live at the September 17 Virtual Investor Forum
Live Presentations and Q&A Across Oncology, Fibrosis, Drug Delivery, Antibiotics, Cannabinoid Therapeutics, and Respiratory Imaging A Global Lineup Presents Live Online: 30-Minute Sessions, Audience Q&A, Replays On Demand NEW YORK, NY - Sept...
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE / AstraZeneca, BioNTech SE, cancer, OncoDaily, Oncology, Vikas Sehdev
Darcy Burbage։ Does ePRO Implementation Require More Oncology Nursing Society?
Darcy Burbage։ Does ePRO Implementation Require More Oncology Nursing Society? / ASCOQLTY26, cancer, Darcy Burbage, electronic patient-reported outcomes,
OncoDaily at ESMO 2026: Where Science Meets Community
OncoDaily at ESMO 2026: Where Science Meets Community / Andrea Necchi, Big Questions in Oncology, bladder cancer, esmo 2026, ESMO Congress, healthcare
Oncology providers ready to swipe right on mobile health apps
Oncology providers are embracing the potential for mobile health apps to support cancer patients, highlighting opportunities for inclusive, evidence-based care.
Legends of Science and Surfing: Riding waves for cancer research
The 33rd annual Legends of Science and Surfing in La Jolla featured an oncology symposium and fundraiser benefiting cancer research at the UC San Diego Moores Cancer Center.
UConn Health Offers New Level of Precision in Cancer Care
High-tech radiation therapy machine enhances accuracy, safety
GSK sees blockbuster potential in targeted cancer therapy after promising early data
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early data showed the drug helped shrink tumors in patients with advanced, hard-to-treat cancers.
Fellowship-Trained Neuro-Oncologist Nishika Karbhari, MD, Joins Baptist Health Herbert Wertheim Cancer Institute
Fellowship-trained neuro-oncologist Nishika Karbhari, M.D., has joined Baptist Health Herbert Wertheim Cancer Institute. Prior to joining Baptist Health, Dr. Karbhari completed a neuro-oncology fellowship at Mayo Clinic in Rochester, MN. She previously completed an internal medicine internship and neurology residency at Dartmouth Health in Lebanon, NH, serving as academic chief resident during her final year. […]
The anti-inflammatory diet: What cancer survivors need to know
Dietitian Eve Lahijani, of the Simms/Mann UCLA Center for Integrative Oncology, discussed the benefits of an anti-inflammatory diet, at the Women's Cancer Survivors Conference.
Tung-Sung Tseng: Honored to Receive the Team Science Champion Award for Tobacco-Related Cancer Research
Tung-Sung Tseng: Honored to Receive the Team Science Champion Award for Tobacco-Related Cancer Research / cancer, LTCI, OncoDaily, Oncology, Team Science
Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology
Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology /
Tackling the Health Care Interoperability Problem | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Over 50M Americans live in counties without a radiation oncology clinic
Between 2018 and 2025, practice sites disproportionately disappeared from rural areas, along with freestanding and community-based settings, ASTRO reports.
Less sleep = less health; Led Zeppelin in the OR; dangers of people-pleasing; plus other stories with Vanderbilt Health sources
Prevention interviewed Beth Malow, MD, Professor of Neurology and Pediatrics in the Vanderbilt Sleep Division, for a story about two randomized trials published in Annals of Internal Medicinethat found decreasing sleep by just 1.5 hours each night was linked with increases in body weight, waist circumference, and sedentary time in adults with elevated cardiometabolic risk. Yahoo Healthalso picked up the story. WTVF News Channel 5 reporter Nikki Hauser interviewed Ashish Shah, MD, Professor and Chair of Cardiac Surgery, for a new video podcast series called “Why Nashville” where she interviews interesting people doing interesting work about why they came to Nashville and how it is going. Among the revelations: his go-to OR music includes Led Zeppelin and AC/DC. Everyday Health interviewed Aaron Brinen, PsyD, Assistant Professor of Psychiatry and Behavioral Sciences, for a story about the TikTok trend that encourages women to speak up about their concerns or they’ll develop an autoimmune disease. Overall, people suggest that suppressing feelings of anger, minimizing your own needs, or people-pleasing raises your risk. Telemundo Nashville broadcast a story on cyclosporiasis that quotes both William Schaffner, MD, professor of Preventive Medicine, and Juan C. Salazar, MD, MPH, chair of the Department of Pediatrics and system Pediatrician-in-Chief for Monroe Carell Jr. Children’s Hospital at Vanderbilt. Schaffner also spoke to WKRN News 2 about measles and The Cutabout shingles and long distance running. WREG (Memphis) and others picked up the measles story as well. CNN reporter Deidre McPhillips interviewed John Trahanas, MD, Assistant Professor of Cardiac Surgery, and Director of Thoracic Aortic Surgery, for a story about aortic dissection in last week’s death of U.S. Sen. Lindsey Graham. The Nashville Post published a story by freelance reporter Leah Hunter on robotic surgery, including a patient story and numerous quotes from Sekhar Padmanabhan, MD, Assistant Professor of Surgery in the Division of Surgical Oncology.
RWJBarnabas Health and Rutgers Cancer Institute Among Only Six Health Systems Nationwide to Earn ASTRO APEx Accreditation for Excellence in Radiation Oncology Care
RWJBarnabas Health and Rutgers Cancer Institute have earned systemwide accreditation from the American Society for Radiation Oncology (ASTRO), becoming one of only six health systems nationwide to achieve APEx accreditation across 10 or more locations. This prestigious recognition underscores our commitment to delivering the highest standards of safety, quality and patient-centered radiation oncology care.
AACR Data Science and Artificial Intelligence in Oncology Conference 2027 - Oncology News, Insights, Stories by OncoDaily
The AACR Data Science and Artificial Intelligence in Oncology Conference 2027 will take place from March 4–7, 2027, at the Hyatt Regency San Francisco
Veterans face surprising threat after cancer diagnosis, study reveals
A new JAMA Oncology study finds veterans with cancer face elevated suicide risk that can persist for up to five years following their diagnosis.
Oracle Health rolls out AI solutions for RCM, oncology as part of broader healthcare, life sciences strategy
ORLANDO, Fla.—Healthcare is entering an AI era, and the industry needs a fundamentally different architecture designed for AI from the start, Oracle Health executives said Wednesday. | Healthcare is entering an AI era, and the industry needs a fundamentally different architecture designed for AI from the start, Oracle Health executives said Wednesday.
Agamon Health Announces New Automated Chart Prep Capability
/PRNewswire/ -- Agamon Health, an AI-powered healthcare technology company focused on automating operational workflows in oncology, announces commercial...
Microbiome science merges with oncology for better cancer treatments
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the resident microbiota, to evade immune surveillance and resist conventional therapies.
GenomeWeb Best Places to Work Winner (26-50 Employees): Genomate Health
Genomate Health, a Cambridge-based computational oncology company, has won GenomeWeb's Best Places to Work award in the 26-50 employee category for the second consecutive year.
SGMC Health Welcomes Centers as Director of Pearlman Cancer Center
SGMC Health is pleased to welcome Nicole Centers as Administrative Director of Oncology and Director of the Pearlman Cancer Center.
First-of-its-kind discovery earns UT Health San Antonio Mays Cancer Center fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
Different uniform, same mission
Tim Barnes, the clinical manager for radiation oncology, has spent 17 years with ECU Health, but started his career in law enforcement.
Construction starts on 7th Highlands Oncology Center
Springdale-based cancer-care provider Highlands Oncology recently broke ground on a five-story, 125,000-square-foot cancer-care center along Interstate 49 in the Pinnacle Hills area of Rogers. The Rogers Cancer Center at 4872...
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned...
Radiation oncologists converge on Capitol Hill to push for payment reform
American Society for Radiation Oncology members from across the country took part in ASTRO’s annual advocacy day on April 27.
Eric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology
Eric Deutsch: The Science Is Expanding Fast at the Interface of Radiation Oncology, Immunology, and Technology / Andy Minn, Anna Wu, Arta Monjazeb, cancer,
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
1 in 3 eligible Americans avoid colorectal cancer (CRC) screenings because traditional methods are viewed as unpleasant and inconvenient Guardant's FDA-approved Shield blood test offers an easier, more convenient way to screen with a blood draw from any prescribing healthcare provider for adults 45+ at average risk for CRC Motivated by his mother’s cancer fight, Dempsey is calling on Americans to prioritize getting screened this CRC Awareness Month Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its partnership with actor and cancer advocate Patrick Dempsey to increase awareness about colorectal cancer (CRC) screening and the Shield® blood test. Approved by the U.S. Food and Drug Administration (FDA) in 2024 and recommended in national guidelines , Shield offers an easier way to screen for colorectal cancer (CRC) with just a blood draw for eligible individuals 45 and over at average risk for the disease. Patrick Dempsey, actor and cancer
RADIATION BUSINESS SOLUTIONS ENCOURAGES INDUSTRY-WIDE FEEDBACK ON PROPOSED MEDICARE PAYMENT CHANGES
Radiation Business Solutions (RBS) urges radiation oncology providers and industry leaders nationwide to join ongoing advocacy efforts concerning the CMS proposed CY 2027 Medicare Physician Fee Schedule.
McKesson makes major $2.25B oncology drug development acquisition
The Texas-based company is buying Precision Medicine Group, a Maryland-based company that supports cancer drug development with a variety of resources, including data and labs.
Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation
TOKYO, May 11, 2026--Daiichi Sankyo (TSE: 4568) today revealed its next Five-Year Business Plan (FY2026 - FY2030) that outlines how the company plans to deliver more than 2.3 trillion yen in oncology revenue by 2030 and be a global top five oncology company by 2035 as part of its larger 2035 Vision to be recognized as a "trusted healthcare innovator transforming the lives of people through science and technology."
E-bike safety; lung cancer treatment and prevention; keeping CMA Festival attendees safe; plus other stories with Vanderbilt Health sources
WKRN News 2 interviewed Jeffrey Upperman, MD, FACS, Professor and Chair of the Department of Pediatric Surgery and Surgeon-in-Chief of Monroe Carell Jr. Children’s Hospital at Vanderbilt, about e-bike related injuries following the recent death of a Brentwood High student and a proposal to require safety training before students could ride a bike on a school campus in Williamson County. Fabien Maldonado, MD, MSc,Professor of Medicine and Thoracic Surgery, was on WTVF News Channel 5‘s live studio show, “Openline,” with host Ben Hall, to discuss lung cancer, treatment and prevention. WSMV’s “Today In Nashville” program hosted Vanderbilt LifeFlight paramedic/flight nurse practitioner Tony Smith to talk about safety for the CMA Festival. The New York Times reporter Carl Zimmer interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about the race to find vaccines and treatments as Ebola spreads. The Vanderbilt Health News release about the pilot clinical trial conducted by Vanderbilt Health and Cumberland Pharmaceuticals Inc., that confirms the safety of ifetroban and supports the further development of the drug to prevent cancer metastasis, was picked up by Reuters, Stock Titan,and others. Women We Admire has named Lee Ann Liska, President and Chief Operating Officer, to its list of top women leaders of Nashville for 2026. Radiology Business, Aunt Minnie, Bioengineer, and Imaging Technology News covered the study from Consuelo Wilkins, MD, MSCI, the Mildred Thornton Stahlman Professor in Rural Health and professor of Medicine in the Division of Geriatric Medicine, that found Black and Hispanic people, while known to be far more apt to have dementia, are significantly less apt than other racial and ethnic groups to show Alzheimer’s pathology on brain scans. STAT News interviewed Deva Sharma, MD, Transfusion Medicine & Hematology-Oncology, for a story about more patients requesting unvaccinated blood and what it means for the medical system at large. Yahoo! Health reporter Korin Miller interviewed Gitanjali Srivastava, MD, Director of Obesity Medicine, for a story about how semaglutide and tirzepatide compare. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: NBC News (new COVID vaccinations); Medscape (pneumonia and sepsis); and CNN (protection from contagious viruses). Shelbyville Times-Gazette is repurposing Jessica Pasley’s July 2025 Vanderbilt Health News story on tick-borne illnesses as a front-page story.
Seven Virginia Tech faculty elected to 2026 Virginia Academy of Science, Engineering, and Medicine
The new members represent the university's research breadth in wireless communications, cybersecurity, cancer biology, medical education, AI, drug delivery, and comparative oncology.
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
PALO ALTO, Calif., October 08, 2026--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Assertio completes $166M merger with Zydus following bidding war
The deal leaves Lake Forest-based Assertio, which specializes in oncology drugs, as a wholly-owned subsidiary of Zydus Lifesciences.
Advances in Oncology Treatment Are Changing the Way Cancer Is Detected and Treated at Broward Health
Dr. Sajive Aleyas performing the first case with the Ion Endoluminal System. Cancer care is evolving as researchers and physicians gain a deeper understanding of how cancer develops, progresses and responds to treatment. Advances in molecular testing, imaging, minimally invasive procedures and targeted therapies are giving physicians more information to guide decisions and patients access […]
Guardant Health (GH) Valuation Check After Strong 1 Year Return And Recent 90 Day Pullback
Guardant Health (GH) has drawn fresh attention as investors look at its recent share performance alongside its growing precision oncology business, including liquid biopsy tests and data services for cancer detection and treatment decisions. See our latest analysis for Guardant Health. At a latest share price of US$93.83, Guardant Health has seen a sharp 10.9% 7 day share price return and a 1 year total shareholder return above 100%. However, the 90 day share price return of a 7.77% decline...
Becker’s Hospital Review Names RWJBarnabas Health and Rutgers Cancer Institute to 2026 “100 Hospitals and Health Systems
RWJBarnabas Health, together with Rutgers Cancer Institute, the state's only National Cancer Institute-designated Comprehensive Cancer Center, has been named to Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs list for 2026, for the fourth consecutive year.
The 10 largest imaging center operators in the US
RadNet tops the list with approximately 383 outposts at the time of the analysis, followed by the US Oncology Network (141), a chain of independent cancer docs backed by McKesson.
ASCO Remembers Dr. Harold P. Freeman, Preeminent Health Equity Expert and Pioneer of Patient Navigation
ASCO joins the oncology community in mourning the death of Harold P. Freeman, MD, a world-renowned expert on and advocate for health equity and the pioneer of patient navigation services in oncology. ...
Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute
September 4, 2026 – Matthew D. Hall, M.D., MBA, lead pediatric radiation oncologist at Baptist Health Herbert Wertheim Cancer Institute, part of Baptist Health Cancer Care, was formally installed as the Endowed Chair in Pediatric Radiation Oncology during a ceremony and reception held September 2 at Mr. C Miami in Coconut Grove. The installation ceremony […]
New CEO selected to lead Proteus
Proteus Inc. has named Sarah Zeidler its new CEO. Zeidler will join the Des Moines-based nonprofit in mid-October, succeeding Daniel Zinnel, who stepped down in July to become CEO of Orchard Place. Zeidler most recently served as executive director of oncology services at UnityPoint Health’s John Stoddard Cancer Center. She also serves on the boards…
CaroMont Health Opens CaroMont Hematology & Oncology in Belmont
CaroMont Health has opened CaroMont Hematology & Oncology in Belmont, expanding access to cancer and blood disorder care across the region. Located in the CaroMont Health Medical Pavilion on the campus of CaroMont Regional Medical Center in Belmont, the practice offers physician visits, infusion therapy and laboratory services in one convenient location, along with comprehensive hematology and medical oncology care including chemotherapy, immunotherapy, targeted therapy, hormone therapy and survivorship support. The opening is part of CaroMont Health's $200 million investment in cancer care, the second largest investment in the health system's history, which will double its oncology capacity across the region.
New UI clinic pilots exercise treatments to improve health of cancer patients, survivors
A new exercise oncology research clinic at the University of Iowa is helping people dealing with cancer and its aftermath build back strength and trust in their bodies through exercise training.
Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for...
Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
Daiichi Sankyo has postponed its annual report by two weeks to allow for additional time to finalize the financial figures. | Daiichi Sankyo has postponed its annual report by two weeks, citing additional time needed to review “the supply plans for its oncology products portfolio and development pipeline.”
Empowering Youth to Drive Progress in Cancer Awareness and Prevention - Zambian Cancer Society
Empowering Youth to Drive Progress in Cancer Awareness and Prevention - Zambian Cancer Society / cancer, Modester Kulongwe Chingadza, OncoDaily, Oncology,
CVS Health (CVS) Stock Still Looks Reasonable On Its 40% 3 Year Return
CVS Health has delivered a solid multi‑year return while the share price has recently pulled back, which puts fresh attention on whether the current valuation is still supported by its earnings power. With new initiatives in areas like oncology care and behavioral health in the mix, the key issue for you is how much of that story is already reflected in today's price. Over the past 3 years CVS Health has returned about 40.0%, which raises the question of how much of its earnings strength is...
What Happens When Science Leads Us in an Unexpected Direction? - Revolution Medicines
What Happens When Science Leads Us in an Unexpected Direction? - Revolution Medicines / cancer, Jan Smith, OncoDaily, Oncology, Revolution Medicines
Prisma Health hosts 20th Dragon Boat Festival, raising thousands for cancer research
The Dragon Boat event mainly supports the Prisma Health Cancer Institute’s Center for Integrative Oncology and Survivorship program.
How to Generate Evidence for RLTs? - European Organisation for Research and Treatment of Cancer
How to Generate Evidence for RLTs? - European Organisation for Research and Treatment of Cancer / cancer, EANM26, OncoDaily, Oncology
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos
In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads. The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care.
Recent billing code changes wreaking havoc for radiation oncologists, new survey finds
“This is a financial emergency for our practice,” one physician says, according to a new survey from the American Society for Radiation Oncology.
James Hamrick Highlights Caris Life Sciences and Precision Oncology Alliance Research at WCLC26
James Hamrick Highlights Caris Life Sciences and Precision Oncology Alliance Research at WCLC26 / cancer, Caris Life Sciences, Caris Precision Oncology
Michigan Medicine, UM Health-Sparrow expand precision oncology program
University of Michigan Health-Sparrow and Michigan Medicine are expanding the use of precision oncology in Lansing.
Four Lake Norman hospitals seek approval for 3D body scanner. Only one will get it
Atrium, Duke Health, Novant and Southern Oncology compete to set up a 3D body scanner outside Charlotte.
Gilead opens new research centre bringing together oncology, inflammation and research data science teams
The centre in California supports the company’s $32bn US investment
Maria Hafez: Can Medical Research Go Beyond Publications to Create Real Impact?
Maria Hafez: Can Medical Research Go Beyond Publications to Create Real Impact? / cancer, Maria Hafez, OncoDaily, Oncology
50 children in our area hit by cars every year; toxic pond water in Centennial Park; ‘gas station heroin’; plus other stories with Vanderbilt Health sources
In a news report following a Murfreesboro child who was killed by an automobile, reporter Amber Jayanth from WSMV Channel 4 News cited statistics gathered at Monroe Carell Jr. Children’s Hospital at Vanderbilt about pediatric pedestrian injuries. Trauma registry data from Monroe Carell indicates that about 50 children per year on average are treated after being hit by a car. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: CNN (mRNA flu vaccine); ABC News and the American Journal of Managed Care (Pennsylvania measles outbreak); News Channel 5 (blue-green algae in the pond at Centennial Park, which can release toxins that make people and pets sick). WSMV Channel 4 News interviewed Saumya Aujla, MD, Assistant Professor of Clinical Physical Medicine and Rehabilitation, about the health risks of kratom, sometimes called “gas station heroin,” and why Tennessee banned the drug. WTVF News Channel 5 interviewed Brianna Smith, MD, Assistant Professor of Pediatrics, Hematology/Oncology at Monroe Carell Jr. Children’s Hospital at Vanderbilt for a piece on Childhood Cancer Awareness Month. Prevention interviewed Mitchell Gigandet, MD, Assistant Professor in the Neuro-Sleep Division, for a story about MDPI research on caffeine that used EEG imaging to see how the drug impacts sleep. It was found that caffeine may make sleep less restorative even when you fall asleep normally and stay in bed for eight hours. The Wall Street Journal reporter Laura Landro interviewed Joseph Schlesinger, MD, Professor of Anesthesiology Critical Care Medicine, for a story about ICU alarms keeping patients from getting sleep and creating alarm fatigue for nurses. Billboard reporter Melinda Newman interviewed country star Dasha about her upcoming vocal surgery at Vanderbilt Health. The story was picked up by numerous print and radio outlets including People.
RWJBarnabas, Hackensack Meridian Health cited by Becker’s for oncology programs
RWJBarnabas Health, Rutgers Cancer Institute and Hackensack Meridian Health have been named to Becker’s Hospital Review.
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.